TL;DR
High myopia macular degeneration typically progresses slowly, often over many years or even decades. But the speed varies widely from person to person, and certain complications can cause sudden, severe vision loss with very little warning. If you have high myopia, knowing what to expect and what to watch for can make a real difference to your long-term sight.
It’s usually a slow process, but not always
For most people with high myopia, the changes that lead to myopic macular degeneration happen gradually. The eyeball continues to elongate over time, stretching the retina a little more each year. This thinning and stretching causes slow, progressive damage to the macula, and many people won’t notice meaningful changes in their vision for years.
A large study that followed myopic adults over 12 years found that only around 10% of those without existing macular damage went on to develop myopic macular degeneration in that time. For people who already had early signs of the condition, roughly 12% saw it progress further over the same period. These aren’t fast numbers, and they suggest that for the majority of people with high myopia, the condition moves at a steady, manageable pace.
That said, there’s an important exception. If abnormal blood vessels start growing beneath the macula, a complication known as choroidal neovascularisation (CNV), the situation can change very quickly. CNV can cause sudden blurred or distorted vision, sometimes within days or weeks. Without prompt treatment, the leaking blood vessels can scar the macula and lead to permanent central vision loss in as little as five years. We’ll go into more detail on CNV below.
What determines how quickly high myopia macular degeneration progresses?
Several factors influence whether myopic macular degeneration stays stable or worsens over time. Some of these are within your control, while others aren’t.
How severe your myopia is
This is the single biggest predictor. The more myopic you are, the longer your eyeball, and the more the retina has to stretch. Research has consistently shown that each additional millimetre of eye length increases the risk of macular damage progressing to its next stage. If your prescription is around -6.00 dioptres, your risk is elevated. At -10.00 or beyond, the risk climbs significantly higher.
Your age
Myopic macular degeneration becomes more common and tends to progress faster as you get older. This is partly because the retina has had more years of mechanical stretching, and partly because ageing brings its own set of changes to the tissues at the back of the eye.
Studies have found that people over 60 with high myopia are at the greatest risk of developing new macular damage or seeing existing damage worsen.
How advanced the condition already is
This one follows a pattern you’d expect: the further along the condition is, the more likely it is to keep progressing. A large meta-analysis found that eyes with more advanced macular changes at baseline were significantly more likely to worsen over time compared to those with only mild, early signs. Once the retina has started to thin noticeably or patches of chorioretinal atrophy have formed, the condition tends to pick up pace.
Eye length and choroidal thickness
Your eye care professional may measure your axial length (the front-to-back length of your eye) using specialist imaging. Longer eyes are more strongly associated with macular damage.
The thickness of the choroid, the blood vessel layer beneath the retina, also matters. A thinner choroid has been linked to faster progression and is considered one of the strongest predictors of how the condition will behave over the coming years.
The stages of myopic macular degeneration
Eye specialists classify myopic macular degeneration into stages based on what they can see at the back of your eye. The system most commonly used is the META-PM classification, which groups the condition into five categories.
In the earliest stage, there’s a tessellated (tiled) appearance to the back of the eye. This happens because the retina is thin enough for the choroidal blood vessels beneath to become visible. Most people at this point have no symptoms at all.
As the condition progresses, diffuse chorioretinal atrophy develops, meaning the tissue at the back of the eye is thinning more broadly. Many people at this stage still have good functional vision, particularly if the damage hasn’t reached the very centre of the macula.
In the later stages, the atrophy becomes patchy and more concentrated, eventually affecting the macula directly. This is when central vision starts to suffer noticeably, and these advanced stages carry a much higher risk of serious gradual vision loss.
Not everyone moves neatly through these stages. Some people remain stable at an early stage for decades, while others may develop complications like CNV at any point.
When progression speeds up
The atrophic changes described above tend to move slowly. But there are two situations where things can accelerate.
Choroidal neovascularisation (CNV)
CNV is the most serious complication of myopic macular degeneration. It develops in roughly 5-10% of people with pathological myopia and can occur at any age, including in younger adults. When abnormal blood vessels grow beneath the macula, they’re fragile and prone to leaking fluid and blood. This causes a sudden drop in central vision, often within days.
The good news is that CNV responds well to treatment with anti-VEGF injections. These drugs block the protein that drives abnormal blood vessel growth, and clinical trials have shown they can stabilise or even improve vision in many cases. Importantly, the number of injections needed for myopic CNV is usually fewer than for age-related macular degeneration, so the treatment burden tends to be lighter.
The key is acting fast. If you notice any sudden change in your central vision, such as new distortion, a dark spot or blurred detail, you’ll need to see a specialist urgently. Early treatment gives the best chance of a good outcome.
Macular atrophy after CNV
Even after CNV has been treated successfully, there’s a long-term risk that macular atrophy can develop around the site where the abnormal blood vessels were. One study found that about a third of treated eyes developed this atrophy within five years. Older patients and those with larger CNV lesions at the time of treatment were at highest risk. This is why ongoing monitoring matters, even once the immediate threat of CNV has been dealt with.
What can you do?
You can’t reverse the retinal stretching that high myopia causes, but you can catch problems before they cause lasting damage.
Regular eye exams are the most important step. If you have high myopia, your optician or ophthalmologist should be examining the back of your eye at every visit, checking for retinal thinning, atrophy or early CNV. Don’t wait for symptoms to appear before booking an appointment.
Between visits, an Amsler grid is a useful tool for monitoring your central vision at home. If any of the lines appear wavy, broken or missing, contact your eye care professional straight away.
Supporting your eye health with the right nutrients can also play a role. Lutein, zeaxanthin, zinc and omega-3 fatty acids have all been linked to better macular health. You’ll find these in leafy greens, oily fish, colourful fruits and vegetables, and targeted supplements.
Finally, protect your eyes from injury. Highly myopic eyes have thinner, more fragile retinas, which makes them more vulnerable to retinal tears or detachment from physical impact.
Related read: 9 Best Foods For Eye Health
Slow doesn’t always mean safe
For most people, high myopia macular degeneration is a slow-moving condition. Many will live with early changes for years without any noticeable impact on their daily life. But because complications like CNV can strike suddenly and cause rapid vision loss, staying on top of your eye health is essential. Regular check-ups, self-monitoring at home and knowing when to seek urgent care are the best tools you have.
